Striverdi Respimat (Boehringer Ingelheim Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Striverdi Respimat drug offered from Boehringer Ingelheim Pharmaceuticals, Inc.. This beta2-Adrenergic Agonist [EPC],Adrenergic beta2-Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Boehringer Ingelheim Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: olodaterol respimat inhalation spray
SUBSTANCE NAME: OLODATEROL HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: beta2-Adrenergic Agonist [EPC],Adrenergic beta2-Agonists [MoA]
ROUTE: RESPIRATORY (INHALATION)
DOSAGE FORM: SPRAY, METERED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2014-08-01
END MARKETING DATE: 0000-00-00


Striverdi Respimat HUMAN PRESCRIPTION DRUG Details:

Item DescriptionStriverdi Respimat from Boehringer Ingelheim Pharmaceuticals, Inc.
LABELER NAME: Boehringer Ingelheim Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 2.5(ug/1)
START MARKETING DATE: 2014-08-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0597-0192_8f0d33cf-7cb8-0605-7f82-ce46e453d103
PRODUCT NDC: 0597-0192
APPLICATION NUMBER: NDA203108

Other OLODATEROL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Boehringer Ingelheim Pharmaceuticals, Inc.Striverdi Respimat